Clinical Trials Logo

Clinical Trial Summary

Secondary Data Collection Study; safety and effectiveness of Tigecycline .under Japanese medical practice


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01789905
Study type Observational
Source Pfizer
Contact
Status Completed
Phase
Start date April 15, 2013
Completion date June 16, 2017

See also
  Status Clinical Trial Phase
Withdrawn NCT04240288 - Procalcitonin Guided Antibiotic Therapy N/A
Completed NCT01431326 - Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Completed NCT01473836 - A Phase 3 Study Of Intravenous Metronidazole For Intrabdominal Infection Phase 3
Terminated NCT03354754 - LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Intra-abdominal Infection (cIAI) Phase 2
Completed NCT00965848 - A Safety and Efficacy Study of Doripenem in Participants With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Urinary Tract Infections Phase 4
Completed NCT01506271 - Study of the Safety, Tolerability, and Efficacy of Relebactam (MK-7655) + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone to Treat Complicated Intra-Abdominal Infection [cIAI] (MK-7655-004) Phase 2
Completed NCT05628493 - Gut Microbiota Analysis in IAI Patients With Sepsis-associated Liver Dysfunction
Completed NCT02442596 - Abdominal SepsiS Study: Epidemiology of Etiology and Outcome N/A
Recruiting NCT04094818 - HostDx Sepsis in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections and Suspected Sepsis
Withdrawn NCT05639504 - Sepsis Prognosis and Diagnosis in the Emergency Department (SPEED)
Completed NCT00827541 - Post-Authorization Study Evaluating Safety Of Tigecycline N/A